Skip to main content
Top
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Stroke | Research

Acute ischemic stroke in Tsutsugamushi: understanding the underlying mechanisms and risk factors

Authors: Dain Kim, Yeon Hee Cho, Jeong Bin Bong, Young Seo Kim, Byoung-Soo Shin, Hyun Goo Kang

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Tsutsugamushi (scrub typhus) is an acute infectious febrile disease common in the Asia-Pacific region. Common symptoms of tsutsugamushi include lymphadenopathy, fever, and myalgia, and it rarely causes acute ischemic stroke (AIS). However, we hypothesized that tsutsugamushi infection could trigger AIS.

Method

We retrospectively examined patients diagnosed with AIS within 2 weeks of tsutsugamushi diagnosis at three hospitals over a 15-year period. We categorized patients who developed AIS while being treated for tsutsugamushi as the case group and those (of similar age and sex) who did not develop AIS as the control group. The case and control groups consisted of 22 and 66 participants, respectively. When a scattered pattern was observed or lesions were found in two or more vascular territories on diffusion-weighted imaging, the pattern was defined as embolic. Other patterns were defined as nonembolic.

Results

Among the 19 patients, excluding three with transient ischemic stroke, 15 (78.9%) showed an embolic pattern. Although fever was common in the control group, it was less common in the case group. A higher D-dimer level at the time of hospitalization was associated with the development of AIS in patients with tsutsugamushi.

Conclusions

AIS in patients with tsutsugamushi showed an embolic rather than a non-embolic pattern on brain magnetic resonance imaging. It was more likely to occur in patients with risk factors for stroke. Tsutsugamushi patients with AIS were likely to have no fever or high D-dimer levels. We hypothesized that D-dimers play an important role in the pathophysiology, where tsutsugamushi infection increases the likelihood of AIS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Walker DH. Scrub typhus - scientific neglect, ever-widening impact. N Engl J Med. 2016;375:913–5.CrossRefPubMed Walker DH. Scrub typhus - scientific neglect, ever-widening impact. N Engl J Med. 2016;375:913–5.CrossRefPubMed
2.
go back to reference Korea Disease Control and Prevention Agency. Surveillance Statistics of Infectious Diseases for week 9, 2023. PHWR Public Health Wkly Rep; 2003. Korea Disease Control and Prevention Agency. Surveillance Statistics of Infectious Diseases for week 9, 2023. PHWR Public Health Wkly Rep; 2003.
3.
go back to reference Sebastian S, Stein LK, Dhamoon MS. Infection as a stroke trigger: associations between different organ system infection admissions and stroke subtypes. Stroke. 2019;50:2216–8.CrossRefPubMed Sebastian S, Stein LK, Dhamoon MS. Infection as a stroke trigger: associations between different organ system infection admissions and stroke subtypes. Stroke. 2019;50:2216–8.CrossRefPubMed
4.
go back to reference Lee HJ, Park CY, Park SG, Yoon NR, Kim DM, Chung CH. Activation of the coagulation cascade in patients with scrub typhus. Diagn Microbiol Infect Dis. 2017;89:1–6.CrossRefPubMed Lee HJ, Park CY, Park SG, Yoon NR, Kim DM, Chung CH. Activation of the coagulation cascade in patients with scrub typhus. Diagn Microbiol Infect Dis. 2017;89:1–6.CrossRefPubMed
5.
go back to reference Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147–52.CrossRefPubMed Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147–52.CrossRefPubMed
6.
go back to reference Brook RD, Rajagopalan S, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention. 2017, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Soc Hypertens. 2018;12:238. Brook RD, Rajagopalan S, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention. 2017, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Soc Hypertens. 2018;12:238.
7.
go back to reference ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care. 2023;46:19–S40.CrossRef ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care. 2023;46:19–S40.CrossRef
8.
go back to reference Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/AphA, et al. /ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. Circulation. 2019;139:e1082–e43.CrossRefPubMed Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/AphA, et al. /ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. Circulation. 2019;139:e1082–e43.CrossRefPubMed
9.
go back to reference Ishibashi S, Yamashita S, Arai H, Araki E, Yokote K, Suganami H, et al. Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: a randomized, double blind, active- and placebo-controlled, phase 2 trial. Atherosclerosis. 2016;249:36–43.CrossRefPubMed Ishibashi S, Yamashita S, Arai H, Araki E, Yokote K, Suganami H, et al. Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: a randomized, double blind, active- and placebo-controlled, phase 2 trial. Atherosclerosis. 2016;249:36–43.CrossRefPubMed
10.
go back to reference Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380:347–57.CrossRefPubMed Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380:347–57.CrossRefPubMed
11.
go back to reference Kim DM. Clinical features and diagnosis of scrub typhus. Infect Chemother. 2009;41:315–22.CrossRef Kim DM. Clinical features and diagnosis of scrub typhus. Infect Chemother. 2009;41:315–22.CrossRef
12.
go back to reference Chung JH, Yun NR, Kim DM, Lee JW, Yoon SH, Kim SW. Scrub typhus and cerebrovascular injury: a phenomenon of delayed treatment? Am J Trop Med Hyg. 2013;89:119–22.CrossRefPubMedPubMedCentral Chung JH, Yun NR, Kim DM, Lee JW, Yoon SH, Kim SW. Scrub typhus and cerebrovascular injury: a phenomenon of delayed treatment? Am J Trop Med Hyg. 2013;89:119–22.CrossRefPubMedPubMedCentral
13.
go back to reference Park JH, Lee DK, Kwon OD. Cerebral infarction associated with scrub typhus. Korean J Stroke. 2007;9:168–70. Park JH, Lee DK, Kwon OD. Cerebral infarction associated with scrub typhus. Korean J Stroke. 2007;9:168–70.
14.
go back to reference Kim H, Kim JT, Lee JS, Kim BJ, Kang J, Lee KJ, et al. Stroke of other determined etiology: results from the nationwide multicenter stroke registry. Stroke. 2022;53:2597–606.CrossRefPubMed Kim H, Kim JT, Lee JS, Kim BJ, Kang J, Lee KJ, et al. Stroke of other determined etiology: results from the nationwide multicenter stroke registry. Stroke. 2022;53:2597–606.CrossRefPubMed
15.
go back to reference Peter JV, Sudarsan TI, Prakash JA, Varghese GM. Severe scrub typhus infection: clinical features, diagnostic challenges and management. World J Crit Care Med. 2015;4:244–50.CrossRefPubMedPubMedCentral Peter JV, Sudarsan TI, Prakash JA, Varghese GM. Severe scrub typhus infection: clinical features, diagnostic challenges and management. World J Crit Care Med. 2015;4:244–50.CrossRefPubMedPubMedCentral
17.
go back to reference Das S, Ghosh KC, Pulai S, Pulai D, Bhar D, Gangopadhyay PK. Systemic infection and inflammation as trigger factors of ischemic stroke. Ann Neurosci. 2011;18:17–20.CrossRefPubMedPubMedCentral Das S, Ghosh KC, Pulai S, Pulai D, Bhar D, Gangopadhyay PK. Systemic infection and inflammation as trigger factors of ischemic stroke. Ann Neurosci. 2011;18:17–20.CrossRefPubMedPubMedCentral
18.
go back to reference Violi F, Pastori D, Pignatelli P. Mechanisms and management of thrombo-embolism in atrial fibrillation. J Atr Fibrillation. 2014;7:1112.PubMedPubMedCentral Violi F, Pastori D, Pignatelli P. Mechanisms and management of thrombo-embolism in atrial fibrillation. J Atr Fibrillation. 2014;7:1112.PubMedPubMedCentral
19.
go back to reference Awotoye J, Fashanu OE, Lutsey PL, Zhao D, O’Neal WT, Michos ED. Resting heart rate and incident venous thromboembolism: the multi-ethnic study of atherosclerosis. Open Heart. 2020;7:e001080.CrossRefPubMedPubMedCentral Awotoye J, Fashanu OE, Lutsey PL, Zhao D, O’Neal WT, Michos ED. Resting heart rate and incident venous thromboembolism: the multi-ethnic study of atherosclerosis. Open Heart. 2020;7:e001080.CrossRefPubMedPubMedCentral
20.
go back to reference Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, et al. Cancer-associated stroke: pathophysiology, detection and management. Int J Oncol. 2019;54:779–96.PubMedPubMedCentral Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, et al. Cancer-associated stroke: pathophysiology, detection and management. Int J Oncol. 2019;54:779–96.PubMedPubMedCentral
21.
go back to reference Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133:906–18.CrossRefPubMed Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133:906–18.CrossRefPubMed
22.
Metadata
Title
Acute ischemic stroke in Tsutsugamushi: understanding the underlying mechanisms and risk factors
Authors
Dain Kim
Yeon Hee Cho
Jeong Bin Bong
Young Seo Kim
Byoung-Soo Shin
Hyun Goo Kang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03534-1

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue